Slayback Pharma announces FDA approval of Merzee, generic equivalent of Taytulla® with a Competitive Generic Therapy (CGT) Designation
PRINCETON, N.J., Dec. 18, 2020 /PRNewswire/ — Slayback Pharma LLC announced today that it has received final approval for its Abbreviated New Drug Application (ANDA) for...

